121
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Investigating the attenuating effect of telmisartan against radiation-induced intestinal injury using 18F-FDG micro-PET imaging

, , , , , & show all
Pages 446-458 | Received 25 Jan 2021, Accepted 21 Jun 2022, Published online: 15 Aug 2022

References

  • Abd-ElRaouf A, Nada AS, Mohammed NE-DA, Amer HA, Abd-ElRahman SS, Abdelsalam RM, Salem HA. 2021. Low dose gamma irradiation attenuates cyclophosphamide-induced cardiotoxicity in rats: role of NF-κB signaling pathway. Int J Radiat Biol. 97(5):632–641.
  • Amano Y, Yamaguchi T, Ohno K, Niimi T, Orita M, Sakashita H, Takeuchi M. 2012. Structural basis for telmisartan-mediated partial activation of PPAR gamma. Hypertens Res. 35(7):715–719.
  • Amirrashedi M, Ay MR, Sarkar S, Farahani MH. 2020. Normalization of a positron emission tomography scanner. Google Patents.
  • Amirrashedi M, Sarkar S, Ghafarian P, Hashemi Shahraki R, Geramifar P, Zaidi H, Ay MR. 2019. NEMA NU‐4 2008 performance evaluation of Xtrim‐PET: a prototype SiPM‐based preclinical scanner. Med Phys. 46(11):4816–4825.
  • Amirrashedi M, Zaidi H, Ay MR. 2020. Towards quantitative small-animal imaging on hybrid PET/CT and PET/MRI systems. Clin Transl Imaging. 8(4):243–221.
  • Arab HH, Al-Shorbagy MY, Abdallah DM, Nassar NN. 2014. Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLoS One. 9(5):e97193.
  • Arumugam S, Sreedhar R, Thandavarayan RA, Giridharan VV, Karuppagounder V, Pitchaimani V, Afrin MR, Miyashita S, Nomoto M, Harima M, et al. 2015. Telmisartan treatment targets inflammatory cytokines to suppress the pathogenesis of acute colitis induced by dextran sulphate sodium. Cytokine. 74(2):305–312.
  • Bettenworth D, Reuter S, Hermann S, Weckesser M, Kerstiens L, Stratis A, Nowacki TM, Ross M, Lenze F, Edemir B, et al. 2013. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation. J Nucl Med. 54(5):748–755.
  • Bhalodia Y, Sheth N, Vaghasiya J, Jivani N. 2010. Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injury. Ren Fail. 32(9):1088–1094.
  • Bhanja P, Saha S, Kabarriti R, Liu L, Roy-Chowdhury N, Roy-Chowdhury J, Sellers RS, Alfieri AA, Guha C. 2009. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One. 4(11):e8014.
  • Bing SJ, Kim MJ, Ahn G, Im J, Kim DS, Ha D, Cho J, Kim A, Jee Y. 2014. Acidic polysaccharide of Panax ginseng regulates the mitochondria/caspase-dependent apoptotic pathway in radiation-induced damage to the jejunum in mice. Acta Histochem. 116(3):514–521.
  • Bolcaen J, Descamps B, Deblaere K, Boterberg T, De Vos Pharm F, Kalala J-P, Van den Broecke C, Decrock E, Leybaert L, Vanhove C, et al. 2015. 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET), and 18F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: A PET study. Nucl Med Biol. 42(1):38–45.
  • Brewer S, Nair-Gill E, Wei B, Chen L, Li X, Riedinger M, Campbell DO, Wiltzius S, Satyamurthy N, Phelps ME, et al. 2010. Epithelial uptake of [18F] 1-(2′-deoxy-2′-arabinofuranosyl) cytosine indicates intestinal inflammation in mice. Gastroenterology. 138(4):1266–1275.
  • Byrd DW, Doot RK, Allberg KC, MacDonald LR, McDougald WA, Elston BF, Linden HM, Kinahan PE. 2016. Evaluation of cross-calibrated 68Ge/68Ga phantoms for assessing PET/CT measurement bias in oncology imaging for single-and multicenter trials. Tomography. 2(4):353–360.
  • Cavalim Vale AP, dos Santos G, da Silva TP, Mansano N, Chies AB, Chagas EFB, Spadella MA. 2019. Influence of the AT1 receptor antagonists telmisartan and losartan on reproduction and offspring after paternal exposure to ionizing radiation. Reprod Sci. 26(5):639–648.
  • Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. 2010. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist. 15(4):360–371.
  • da Silva Mansano N, Jorge IF, Chies AB, Viani GA, Spadella MA. 2018. Effects of telmisartan and losartan on irradiated testes. Life Sci. 194:157–167.
  • Das CJ, Makharia GK, Kumar R, Kumar R, Tiwari RP, Sharma R, Malhotra A. 2010. PET/CT colonography: a novel non-invasive technique for assessment of extent and activity of ulcerative colitis. Eur J Nucl Med Mol Imaging. 37(4):714–721.
  • Destro M, Cagnoni F, Dognini GP, Galimberti V, Taietti C, Cavalleri C, Galli E. 2011. Telmisartan: just an antihypertensive agent? A literature review. Expert Opin Pharmacother. 12(17):2719–2735.
  • Dörr H, Meineke V. 2011. Acute radiation syndrome caused by accidental radiation exposure-therapeutic principles. BMC Med. 9(1):126.
  • Dutta A, Gupta M, Kalita B. 2015. The combination of the active principles of Podophyllum hexandrum supports early recovery of the gastrointestinal system via activation of Nrf2-HO-1 signaling and the hematopoietic system, leading to effective whole-body survival in lethally irradiated mice. Free Radic Res. 49(3):317–330.
  • Ertay T, Eren MS, Karaman M, Oktay G, Durak H. 2017. 18F-FDG-PET/CT in Initiation and Progression of Inflammation and Infection. Mirt. 26(2):47–52.
  • Fahey FH, Kinahan PE, Doot RK, Kocak M, Thurston H, Poussaint TY. 2010. Variability in PET quantitation within a multicenter consortium. Med Phys. 37(7):3660–3666.
  • Fooladi M, Cheki M, Shirazi A, Sheikhzadeh P, Amirrashedi M, Ghahramani F, Khoobi M. 2022. Histopathological evaluation of protective effect of telmisartan against radiation-induced bone marrow injury. J Biomed Phys Eng. 12(3):277–284.
  • François A, Milliat F, Guipaud O, Benderitter M. 2013. Inflammation and immunity in radiation damage to the gut mucosa. Biomed Res Int. 2013:1–9.
  • Gao Z, Zhang Q, Han Y, Cheng X, Lu Y, Fan L, Wu Z. 2012. Mesenchymal stromal cell-conditioned medium prevents radiation-induced small intestine injury in mice. Cytotherapy. 14(3):267–273.
  • Garg S, Boerma M, Wang J, Fu Q, Loose DS, Kumar KS, Hauer-Jensen M. 2010. Influence of sublethal total-body irradiation on immune cell populations in the intestinal mucosa. Radiat Res. 173(4):469–478.
  • Ghosh SP, Kulkarni S, Perkins MW, Hieber K, Pessu RL, Gambles K, Maniar M, Kao T-C, Seed TM, Kumar KS. 2012. Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD® in mice. J Radiat Res. 53(4):526–536.
  • Gonzalez E, Cruces MP, Pimentel E, Sánchez P. 2018. Evidence that the radioprotector effect of ascorbic acid depends on the radiation dose rate. Environ Toxicol Pharmacol. 62:210–214.
  • Guerra GC, Araújo AA, Lira GA, Melo MN, Souto KK, Fernandes D, Silva AL, Júnior RFA. 2015. Telmisartan decreases inflammation by modulating TNF-α, IL-10, and RANK/RANKL in a rat model of ulcerative colitis. Pharmacol Rep. 67(3):520–526.
  • Hall EJ, Giaccia A. 2006. Radiobiology for the radiologist. Lippincott Williams & Wilkins.
  • Hall S, Rudrawar S, Zunk M, Bernaitis N, Arora D, McDermott CM, Anoopkumar-Dukie S. 2016. Protection against radiotherapy-induced toxicity. Antioxidants. 5(3):22.
  • Hume GE, Radford-Smith GL. 2008. ACE inhibitors and angiotensin II receptor antagonists in Crohn’s disease management. Expert Rev Gastroenterol Hepatol. 2(5):645–651.
  • Ilyin L, Ushakov I, Vasin M. 2013. Radioprotective drugs in the system of radiation protection of exposed radiation workers and population in the case of nuclear accidents. The IRPA13 Abstract Book.
  • Jalal Hosseinimehr S. 2007. Foundation review: Trends in the development of radioprotective agents. Drug Discov Today. 12(19-20):794–805.
  • Khalaf S, Al-Mallah MH. 2020. Fluorodeoxyglucose applications in cardiac PET: viability, inflammation, infection, and beyond. Methodist Debakey Cardiovasc J. 16(2):122–129.
  • Khan S, Kumar A, Adhikari J, Rizvi M, Chaudhury N. 2015. Protective effect of sesamol against 60Co γ-ray-induced hematopoietic and gastrointestinal injury in C57BL/6 male mice. Free Radic Res. 49(11):1344–1361.
  • Khayyal MT, Kreuter MH, Kemmler M, Altmann P, Abdel‐Naby DH, El‐Ghazaly MA. 2019. Effect of a chamomile extract in protecting against radiation‐induced intestinal mucositis. Phytother Res. 33(3):728–736.
  • Kinahan PE, Fletcher JW. 2010. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 31(6):496–505.
  • Lawrence T. 2009. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol. 1(6):a001651.
  • Li XH, Ghosh SP, Ha CT, Fu D, Elliott TB, Bolduc DL, Villa V, Whitnall MH, Landauer MR, Xiao M. 2013. Delta-tocotrienol protects mice from radiation-induced gastrointestinal injury. Radiat Res. 180(6):649–657.
  • Liu Y, Chen S, Liu J, Jin Y, Yu S, An R. 2020. Telmisartan inhibits oxalate and calcium oxalate crystal-induced epithelial-mesenchymal transformation via PPAR-γ-AKT/STAT3/p38 MAPK-snail pathway. Life Sci. 241:117108.
  • Liu T, Zhang L, Joo D, Sun S-C. 2017. NF-κB signaling in inflammation. Sig Transduct Target Ther. 2(1):1–9.
  • Lordick F, Ott K, Krause B-J, Weber WA, Becker K, Stein HJ, Lorenzen S, Schuster T, Wieder H, Herrmann K, et al. 2007. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncolo. 8(9):797–805.
  • Manual A. 2001. Cytogenetic analysis for radiation dose assessment. Technical Report Series-International Atomic Energy Agency.
  • Matsusaka Y, Nakahara T, Takahashi K, Iwabuchi Y, Ogata Y, Nishime C, Kajimura M, Jinzaki M. 2018. Preclinical evaluation of heat-denatured [18F] FDG-labeled red blood cells for detecting splenic tissues with PET in rats. Nucl Med Biol. 56:26–30.
  • Mishra K, Alsbeih G. 2017. Appraisal of biochemical classes of radioprotectors: evidence, current status and guidelines for future development. 3 Biotech. 7(5):292.
  • Moinuddin G, Inamdar MN, Kulkarni KS, Kulkarni C. 2013. Modulation of haemodynamics, endogeneous antioxidant enzymes, and pathophysiological changes by selective inhibition of angiotensin ii type 1 receptors in pressure-overload rats. Cardiovasc J Afr. 24(3):58–65.
  • Mollà M, Panés J. 2007. Radiation-induced intestinal inflammation. WJG. 13(22):3043.
  • Monti P, Wysocki J, Van der Meeren A, Griffiths N. 2005. The contribution of radiation-induced injury to the gastrointestinal tract in the development of multi-organ dysfunction syndrome or failure. BJR. Supplement_27(1):89–94.
  • Morgan R, Chin BB, Lanning R. 2019. Feasibility of rapid integrated radiation therapy planning with follow-up FDG PET/CT to improve overall treatment assessment in head and neck cancer. Am J Nucl Med Mol Imaging. 9(1):24–29.
  • Morsy M, Ashour O, Amin E, Rofaeil R. 2009. Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats. Die Pharm. 64(9):590–594.
  • Patil R, Szabó E, Fells JI, Balogh A, Lim KG, Fujiwara Y, Norman DD, Lee S-C, Balazs L, Thomas F, et al. 2015. Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist. Chem Biol. 22(2):206–216.
  • Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy 2010. Seminars in Ultrasound, CT and MRI. Amsterdam: Elsevier.
  • Richter K, Fagerhol M, Carr J, Winkler J, Sung C, Hauer‐Jensen M. 1997. Association of granulocyte transmigration with structural and cellular parameters of injury in experimental radiation enteropathy. Radiat Oncol Investig. 5(6):275–282.
  • Rodríguez-Fraile M, Cózar-Santiago M, Sabaté-Llobera A, Caresia-Aróztegui A, Delgado-Bolton R, Orcajo-Rincon J, de Arcocha-Torres M, García-Velloso M, García-Talavera P. 2020. FDG PET/CT in colorectal cancer. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 39(1):57–66.
  • Saber S, Basuony M, Eldin AS. 2019. Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity. Arch Biochem Biophys. 671:185–195.
  • Saboury B, Salavati A, Brothers A, Basu S, Kwee TC, Lam MG, Hustinx R, Louis E, Torigian DA, Alavi A. 2014. FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity. Eur J Nucl Med Mol Imaging. 41(4):605–614.
  • Seed TM, Inal CE, Singh VK. 2014. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis. Int J Radiat Biol. 90(7):594–604.
  • Shadad AK, Sullivan FJ, Martin JD, Egan LJ. 2013. Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol. 19(2):185–198.
  • Sharma D, Goel HC, Chauhan S. 2016. Radioprotective potential of Lagenaria siceraria extract against radiation-induced gastrointestinal injury. Appl Physiol Nutr Metab. 41(12):1248–1254.
  • Sharma AA, Szaflarski JP. 2020. In vivo imaging of neuroinflammatory targets in treatment-resistant epilepsy. Curr Neurol Neurosci Rep. 20(4):1–13.
  • Singh VK, Wise SY, Singh PK, Ducey EJ, Fatanmi OO, Seed TM. 2012. α-Tocopherol succinate–and AMD3100-mobilized progenitors mitigate radiation-induced gastrointestinal injury in mice. Exp Hematol. 40(5):407–417.
  • Stansborough RL, Bateman EH, Al-Dasooqi N, Bowen JM, Keefe DM, Yeoh AS, Logan RM, Yeoh EE, Stringer AM, Gibson RJ. 2017. Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicity. Support Care Cancer. 25(6):1973–1983.
  • Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, Dynan WS, Fike JR, Grdina DJ, Greenberger JS, et al. 2004. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries report of an NCI workshop, December 3–4, 2003. Radiat Res. 162(6):711–728.
  • Tang TT, Rendon DA, Zawaski JA, Afshar SF, Kaffes CK, Sabek OM, Gaber MW. 2017. Imaging radiation-induced gastrointestinal, bone marrow injury and recovery kinetics using 18F-FDG PET. PLoS One. 12(1):e0169082.
  • Thierens H, Vral A. 2009. The micronucleus assay in radiation accidents. Ann Ist Super Sanita. 45(3):260–264.
  • Treglia G, Quartuccio N, Sadeghi R, Farchione A, Caldarella C, Bertagna F, Fania P, Cistaro A. 2013. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis. J Crohns Colitis. 7(5):345–354.
  • Uchida H, Nakamura Y, Kaihara M, Sugimoto T, Norii H, Sasaki M, Sato H, Makino H. 2004. Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension. Hypertens Res. 27(8):545–550.
  • Ueda S, Kondoh N, Tsuda H, Yamamoto S, Asakawa H, Fukatsu K, Kobayashi T, Yamamoto J, Tamura K, Ishida J, et al. 2008. Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer. BMC Cancer. 8(1):384–312.
  • Wei Y-L, Xu J-Y, Zhang R, Zhang Z, Zhao L, Qin L-Q. 2019. Effects of lactoferrin on X-ray-induced intestinal injury in Balb/C mice. Appl Radiat Isot. 146:72–77.
  • WHO 2011. Cytogenetic dosimetry: applications in preparedness for and response to radiation emergencies. Vienna (AT): IAEA (International Atomic Energy Agency).
  • Zakeri K, Narayanan D, Vikram B, Evans G, Coleman CN, Prasanna PG. 2019. Decreasing the toxicity of radiation therapy: radioprotectors and radiomitigators being developed by the National Cancer Institute through small business innovation research contracts. Int J Radiat Oncol Biol Phys. 104(1):188–196.
  • Zhang S, Wang Y. 2018. Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway. Oncol Lett. 15(4):5859–5864.
  • Zhang H, Yan H, Zhou X, Wang H, Yang Y, Zhang J, Wang H. 2017. The protective effects of Resveratrol against radiation-induced intestinal injury. BMC Complement Altern Med. 17(1):1–8.
  • Zhuang H, Jian QY, Alavi A. 2005. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am. 43(1):121–134.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.